Last updated: July 24, 2025
Sponsor: Ohio State University
Overall Status: Trial Not Available
Phase
N/A
Condition
N/ATreatment
novel biomarkers of lung disease
Clinical Study ID
NCT02369575
2014H0367
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- any one on lung transplant list
Exclusion
Exclusion Criteria:
- HIV positive
Study Design
Treatment Group(s): 1
Primary Treatment: novel biomarkers of lung disease
Phase:
Study Start date:
February 01, 2015
Estimated Completion Date:
July 31, 2025
Study Description
Connect with a study center
Davis Heart and Lung Research Institute
Columbus, Ohio 43210
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.